2.97
0.01 (0.34%)
0.01 (0.34%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.34% | 2.97 | 2.94 | 3.01 | 3.01 | 2.96 | 16:00:01 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.96 | 2.99 | 0.03 | 1.0% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,305 | 2,469,560 | $ 2.9875 | $ 7,377,730 | 6,791,029 | 0.261 - 3.86 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:29 | formt | 7,950 | $ 2.99 | USD |
CytoDyn (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.53B | 514.73M | 302.11M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 9.54M | $ - | 0.00% | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.15 | 3.24 | 2.78 | 3.00 | 4,438,937 | -0.18 | -5.71% |
| 1 Month | 2.83 | 3.69 | 2.53 | 3.03 | 4,773,200 | 0.14 | 4.95% |
| 3 Months | 1.15 | 3.86 | 0.81 | 2.68 | 7,409,093 | 1.82 | 158.26% |
| 6 Months | 0.2949 | 3.86 | 0.261 | 2.12 | 5,353,379 | 2.68 | 907.12% |
| 1 Year | 0.391 | 3.86 | 0.261 | 1.93 | 2,933,075 | 2.58 | 659.59% |
| 3 Years | 0.6049 | 3.86 | 0.0552 | 1.71 | 1,168,762 | 2.37 | 390.99% |
| 5 Years | 0.99 | 3.86 | 0.0552 | 1.62 | 788,280 | 1.98 | 200.0% |
CytoDyn (QB) Description
| CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology. |
